Precipitating Mechanisms of Falls in Preclinical Alzheimer's Disease

被引:2
|
作者
Keleman, Audrey A. [1 ]
Nicosia, Jessica y [2 ]
Bollinger, Rebecca M. [1 ]
Wisch, Julie K. [2 ]
Hassenstab, Jason [2 ,3 ]
Morris, John C. [2 ,5 ]
Ances, Beau M. [2 ,4 ,5 ]
Balota, David A. [3 ]
Stark, Susan L. [1 ,2 ]
机构
[1] Washington Univ St Louis, Program Occupat Therapy, St Louis, MO USA
[2] Washington Univ St Louis, Dept Neurol, St Louis, MO USA
[3] Washington Univ St Louis, Dept Psychol, St Louis, MO USA
[4] Washington Univ St Louis, Dept Radiol, St Louis, MO USA
[5] Washington Univ St Louis, Hope Ctr Neurol Disorders, St Louis, MO USA
基金
美国国家卫生研究院;
关键词
Alzheimer's disease; cognition; falls; functional mobility; DWELLING OLDER-PEOPLE; RISK-FACTORS; DATA SET; GAIT SPEED; PERFORMANCE; VALIDATION; VERSION; HEALTH; TAU; PREDICTOR;
D O I
10.3233/ADR-230002
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Background: Individuals with Alzheimer's disease (AD) are more than twice as likely to incur a serious fall as the general population of older adults. Although AD is commonly associated with cognitive changes, impairments in other clinical measures such as strength or functional mobility (i.e., gait and balance) may precede symptomatic cognitive impairment in preclinical AD and lead to increased fall risk. Objective: To examine mechanisms (i.e., functional mobility, cognition, AD biomarkers) associated with increased falls in cognitively normal older adults. Methods: This 1-year study was part of an ongoing longitudinal cohort study. We examined the relationships among falls, clinical measures of functional mobility and cognition, and neuroimaging AD biomarkers in cognitively normal older adults. We also investigated which domain(s) best predicted fall propensity and severity through multiple regression models. Results: A total of 182 older adults were included (mean age 75 years, 53% female). A total of 227 falls were reported over the year; falls per person ranged from 0-16 with a median of 1. Measures of functional mobility were the best predictors of fall propensity and severity. Cognition and AD biomarkers were associated with each other but not with the fall outcome measures. Conclusion: These results suggest that, although subtle changes in cognition may be more closely associated with AD neuropathology, functional mobility indicators better predict falls in cognitively normal older adults. This study adds to our understanding of the mechanisms underlying falls in older adults and could lead to the development of targeted fall prevention strategies.
引用
收藏
页码:739 / 750
页数:12
相关论文
共 50 条
  • [1] PREDICTING FALLS OF PRECLINICAL ALZHEIMER'S DISEASE
    Hu, Y.
    Achuck, K.
    Stark, S.
    GERONTOLOGIST, 2016, 56 : 337 - 337
  • [2] Preclinical Alzheimer disease and risk of falls
    Stark, Susan L.
    Roe, Catherine M.
    Grant, Elizabeth A.
    Hollingsworth, Holly
    Benzinger, Tammie L.
    Fagan, Anne M.
    Buckles, Virginia D.
    Morris, John C.
    NEUROLOGY, 2013, 81 (05) : 437 - 443
  • [4] EEG evidence of compensatory mechanisms in preclinical Alzheimer's disease
    Gaubert, Sinead
    Raimondo, Federico
    Houot, Marion
    Corsi, Marie-Constance
    Naccache, Lionel
    Sitt, Jacobo Diego
    Hermann, Bertrand
    Oudiette, Delphine
    Gagliardi, Geoffroy
    Habert, Marie-Odile
    Dubois, Bruno
    Fallani, Fabrizio De Vico
    Bakardjian, Hovagim
    Epelbaum, Stephane
    Benali, Habib
    Bertin, Hugo
    Bonheur, Joel
    Boukadida, Laurie
    Boukerrou, Nadia
    Cavedo, Enrica
    Chiesa, Patrizia
    Colliot, Olivier
    Dubois, Marion
    Genthon, Remy
    Hampel, Harald
    Kas, Aurelie
    Lamari, Foudil
    Levy, Marcel
    Lista, Simone
    Metzinger, Christiane
    Mochel, Fanny
    Nyasse, Francis
    Poisson, Catherine
    Potier, Marie-Claude
    Revillon, Marie
    Santos, Antonio
    Andrade, Katia Santos
    Sole, Marine
    Surtee, Mohmed
    de Schotten, Michel Thiebaud
    Vergallo, Andrea
    Younsi, Nadjia
    BRAIN, 2019, 142 : 2096 - 2112
  • [5] FALLS AND PRECLINICAL ALZEHIMER'S DISEASE
    Stark, S.
    Roe, C. M.
    Morris, J. C.
    GERONTOLOGIST, 2015, 55 : 746 - 746
  • [6] Falls: a marker of preclinical Alzheimer disease: a cohort study protocol
    Bollinger, Rebecca M.
    Keleman, Audrey
    Thompson, Regina
    Westerhaus, Elizabeth
    Fagan, Anne M.
    Benzinger, Tammie L. S.
    Schindler, Suzanne E.
    Xiong, Chengjie
    Balota, David
    Morris, John C.
    Ances, Beau M.
    Stark, Susan L.
    BMJ OPEN, 2021, 11 (09):
  • [7] Memantine Multiple Mechanisms of Action in Preclinical Models of Alzheimer's Disease
    Banerjee, Pradeep K.
    NEUROLOGY, 2011, 76 (09) : A228 - A228
  • [8] Memantine Multiple Mechanisms of Action in Preclinical Models of Alzheimer's Disease
    Banerjee, Pradeep K.
    BIOLOGICAL PSYCHIATRY, 2011, 69 (09) : 27S - 27S
  • [9] Preclinical Alzheimer's disease
    Gil-Gregorio, P.
    Yubero-Pancorbo, R.
    REVIEWS IN CLINICAL GERONTOLOGY, 2014, 24 (02) : 117 - 121
  • [10] Metformin in Alzheimer's disease: An overview of potential mechanisms, preclinical and clinical findings
    Khezri, Mohammad Rafi
    Yousefi, Keyvan
    Mahboubi, Negin
    Hodaei, Darya
    Ghasemnejad-Berenji, Morteza
    BIOCHEMICAL PHARMACOLOGY, 2022, 197